1022150-12-4,
(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
Btk inhibitor 1 R enantiomer,
Btk inhibitor 1 (R enantiomer),
AK161693,
SCHEMBL1614096,
GPSQYTDPBDNDGI-MRXNPFEDSA-N,
2923AH,
HY-13036A,
MFCD20482137,
ZINC95080215,
AKOS024462875,
CS-2435,
DS-7364,
SB17983,
KS-00000S39,
NCGC00378594-02,
SC-20270,
AJ-132049,
AX8273861,
DB-058780,
FT-0697186,
ST24035433,
(R)-3-(4-PHENOXYPHENYL)-1-(PIPERIDIN-3-YL)-1H-PYRA,
(R)-3-(4-phenoxy phenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
(R)-3-(4-PHENOXYPHENYL)-1-(PIPERIDIN-3-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AM INE,
1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(4-phenoxyphenyl)-1-(3R)-3-piperidinyl-,
3-(4-phenoxyphenyl)-1-(3R)-3-piperidinyl-1H-Pyrazolo[3,4-d]pyrimidin-4-amine,
3-(4-phenoxyphenyl)-1-[(3R)-piperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine,
Btk Inhibitor 1 R-Enantiomer,
C22H22N6O,
ACN-028782,
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine,